| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 13 | 2022 | 442 | 4.620 |
Why?
|
| Heart | 22 | 2023 | 850 | 3.070 |
Why?
|
| Regeneration | 8 | 2022 | 105 | 2.610 |
Why?
|
| Pericardium | 8 | 2020 | 97 | 2.550 |
Why?
|
| Insulin-Like Growth Factor II | 5 | 2020 | 52 | 2.370 |
Why?
|
| Receptors, Retinoic Acid | 25 | 2015 | 48 | 2.320 |
Why?
|
| Cell Proliferation | 15 | 2022 | 1173 | 2.140 |
Why?
|
| Heart Ventricles | 10 | 2020 | 738 | 1.840 |
Why?
|
| Signal Transduction | 26 | 2020 | 2688 | 1.790 |
Why?
|
| Morphogenesis | 9 | 2019 | 158 | 1.640 |
Why?
|
| Mesoderm | 8 | 2015 | 231 | 1.560 |
Why?
|
| Tretinoin | 12 | 2011 | 92 | 1.550 |
Why?
|
| Mice | 65 | 2023 | 8472 | 1.540 |
Why?
|
| Transcription Factors | 20 | 2014 | 753 | 1.450 |
Why?
|
| Heart Diseases | 3 | 2023 | 276 | 1.420 |
Why?
|
| Gene Expression Regulation, Developmental | 20 | 2020 | 328 | 1.360 |
Why?
|
| Myocardium | 14 | 2020 | 1204 | 1.330 |
Why?
|
| Neural Crest | 13 | 2012 | 58 | 1.270 |
Why?
|
| Mutation | 15 | 2021 | 1213 | 1.220 |
Why?
|
| Animals | 76 | 2023 | 20877 | 1.210 |
Why?
|
| Endocardium | 5 | 2016 | 101 | 0.970 |
Why?
|
| Alleles | 4 | 2020 | 386 | 0.930 |
Why?
|
| Heart Injuries | 2 | 2021 | 25 | 0.930 |
Why?
|
| Mice, Transgenic | 22 | 2023 | 1032 | 0.920 |
Why?
|
| Polyploidy | 2 | 2019 | 24 | 0.900 |
Why?
|
| Mice, Knockout | 20 | 2022 | 1692 | 0.860 |
Why?
|
| Diploidy | 2 | 2020 | 7 | 0.810 |
Why?
|
| Transforming Growth Factor beta | 5 | 2015 | 384 | 0.780 |
Why?
|
| Vascular Remodeling | 1 | 2021 | 34 | 0.770 |
Why?
|
| Ploidies | 1 | 2020 | 6 | 0.750 |
Why?
|
| Endothelium, Vascular | 6 | 2022 | 371 | 0.730 |
Why?
|
| Muscle Contraction | 1 | 2021 | 210 | 0.730 |
Why?
|
| Coronary Vessels | 4 | 2016 | 313 | 0.730 |
Why?
|
| Erythropoietin | 5 | 2015 | 96 | 0.720 |
Why?
|
| Cell Differentiation | 9 | 2020 | 1034 | 0.710 |
Why?
|
| Fetal Heart | 5 | 2007 | 41 | 0.700 |
Why?
|
| Evolution, Molecular | 1 | 2019 | 79 | 0.690 |
Why?
|
| DNA-Binding Proteins | 7 | 2007 | 700 | 0.690 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2019 | 42 | 0.690 |
Why?
|
| Receptors, Transforming Growth Factor beta | 3 | 2009 | 56 | 0.680 |
Why?
|
| Cell Nucleus | 1 | 2020 | 305 | 0.680 |
Why?
|
| Receptor, Insulin | 1 | 2019 | 71 | 0.680 |
Why?
|
| Embryo, Mammalian | 6 | 2015 | 176 | 0.680 |
Why?
|
| Receptors, CXCR4 | 2 | 2015 | 48 | 0.650 |
Why?
|
| Liver | 9 | 2011 | 1118 | 0.580 |
Why?
|
| Cardiovascular System | 4 | 2005 | 85 | 0.580 |
Why?
|
| Organogenesis | 7 | 2019 | 49 | 0.570 |
Why?
|
| Heart Septal Defects | 1 | 2015 | 27 | 0.550 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2009 | 317 | 0.530 |
Why?
|
| Adipogenesis | 1 | 2015 | 17 | 0.520 |
Why?
|
| Cell Lineage | 5 | 2019 | 146 | 0.520 |
Why?
|
| Chemokine CXCL12 | 1 | 2015 | 51 | 0.520 |
Why?
|
| Branchial Region | 3 | 2011 | 8 | 0.510 |
Why?
|
| Coronary Circulation | 1 | 2015 | 136 | 0.500 |
Why?
|
| Endothelial Cells | 2 | 2022 | 384 | 0.500 |
Why?
|
| PPAR gamma | 1 | 2015 | 95 | 0.490 |
Why?
|
| Homeodomain Proteins | 8 | 2014 | 157 | 0.470 |
Why?
|
| Stem Cells | 3 | 2020 | 248 | 0.460 |
Why?
|
| Zebrafish Proteins | 4 | 2015 | 100 | 0.460 |
Why?
|
| Arteries | 2 | 2022 | 108 | 0.440 |
Why?
|
| Neuropilins | 1 | 2012 | 1 | 0.430 |
Why?
|
| DiGeorge Syndrome | 1 | 2012 | 13 | 0.430 |
Why?
|
| Placenta | 4 | 2023 | 101 | 0.420 |
Why?
|
| Endothelium | 1 | 2012 | 98 | 0.420 |
Why?
|
| Receptors, Notch | 2 | 2022 | 15 | 0.410 |
Why?
|
| Calcium-Binding Proteins | 2 | 2022 | 114 | 0.400 |
Why?
|
| Cadherins | 2 | 2011 | 93 | 0.390 |
Why?
|
| Pregnancy | 10 | 2023 | 2331 | 0.390 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2010 | 19 | 0.370 |
Why?
|
| Zebrafish | 3 | 2017 | 187 | 0.370 |
Why?
|
| Epithelial Cells | 3 | 2023 | 431 | 0.370 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2022 | 214 | 0.370 |
Why?
|
| Cells, Cultured | 7 | 2017 | 2673 | 0.360 |
Why?
|
| Mice, Inbred C57BL | 11 | 2021 | 2790 | 0.350 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2009 | 14 | 0.340 |
Why?
|
| Phenotype | 7 | 2015 | 946 | 0.340 |
Why?
|
| Elastic Tissue | 1 | 2009 | 28 | 0.340 |
Why?
|
| Aneurysm | 1 | 2009 | 53 | 0.340 |
Why?
|
| Genes | 6 | 1998 | 86 | 0.340 |
Why?
|
| Retinoid X Receptors | 12 | 2001 | 26 | 0.340 |
Why?
|
| Mice, Mutant Strains | 6 | 2012 | 166 | 0.330 |
Why?
|
| Calcitonin | 1 | 2007 | 21 | 0.310 |
Why?
|
| Animals, Genetically Modified | 3 | 2017 | 63 | 0.310 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2000 | 66 | 0.310 |
Why?
|
| Thyroid Gland | 1 | 2007 | 67 | 0.300 |
Why?
|
| Genotype | 3 | 2020 | 785 | 0.290 |
Why?
|
| Animals, Newborn | 3 | 2021 | 396 | 0.290 |
Why?
|
| Heart Failure | 1 | 2015 | 1179 | 0.280 |
Why?
|
| Trophoblasts | 2 | 2023 | 29 | 0.280 |
Why?
|
| Cell Movement | 7 | 2012 | 630 | 0.280 |
Why?
|
| Limb Deformities, Congenital | 2 | 1996 | 12 | 0.280 |
Why?
|
| Abnormalities, Drug-Induced | 2 | 1996 | 34 | 0.280 |
Why?
|
| Nuclear Proteins | 4 | 2005 | 271 | 0.270 |
Why?
|
| Erythropoiesis | 2 | 2005 | 24 | 0.270 |
Why?
|
| Fetus | 2 | 2005 | 157 | 0.260 |
Why?
|
| Embryonic and Fetal Development | 5 | 2002 | 74 | 0.260 |
Why?
|
| Mice, Inbred BALB C | 6 | 2020 | 532 | 0.250 |
Why?
|
| Microscopy, Confocal | 3 | 2017 | 337 | 0.250 |
Why?
|
| MSX1 Transcription Factor | 4 | 2008 | 9 | 0.250 |
Why?
|
| Integrases | 4 | 2007 | 31 | 0.240 |
Why?
|
| Hypoxia | 1 | 2005 | 169 | 0.240 |
Why?
|
| Mice, Inbred ICR | 3 | 2015 | 44 | 0.240 |
Why?
|
| Body Patterning | 6 | 2013 | 44 | 0.240 |
Why?
|
| Phosphoproteins | 2 | 2005 | 202 | 0.240 |
Why?
|
| Vitamin A | 2 | 1995 | 111 | 0.240 |
Why?
|
| Gestational Age | 4 | 2015 | 389 | 0.240 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 1293 | 0.230 |
Why?
|
| Female | 19 | 2023 | 38015 | 0.230 |
Why?
|
| Placentation | 1 | 2023 | 6 | 0.230 |
Why?
|
| In Situ Hybridization | 6 | 2011 | 201 | 0.230 |
Why?
|
| Heart Defects, Congenital | 6 | 2007 | 596 | 0.220 |
Why?
|
| Viral Proteins | 2 | 2001 | 149 | 0.210 |
Why?
|
| Base Sequence | 8 | 2014 | 1015 | 0.210 |
Why?
|
| Repressor Proteins | 1 | 2023 | 182 | 0.200 |
Why?
|
| Trans-Activators | 1 | 2023 | 237 | 0.200 |
Why?
|
| Retinoic Acid Receptor alpha | 4 | 2015 | 9 | 0.200 |
Why?
|
| Mammals | 3 | 2022 | 47 | 0.200 |
Why?
|
| Receptors, Erythropoietin | 2 | 2015 | 9 | 0.200 |
Why?
|
| Promoter Regions, Genetic | 5 | 2014 | 614 | 0.190 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2020 | 7 | 0.190 |
Why?
|
| Cryosurgery | 1 | 2021 | 53 | 0.190 |
Why?
|
| Immunohistochemistry | 5 | 2011 | 1174 | 0.190 |
Why?
|
| Guanine Nucleotide Dissociation Inhibitors | 1 | 2020 | 17 | 0.190 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2020 | 18 | 0.190 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2020 | 10 | 0.190 |
Why?
|
| Homeostasis | 2 | 2000 | 291 | 0.190 |
Why?
|
| Tooth | 1 | 2000 | 24 | 0.190 |
Why?
|
| Sea Urchins | 4 | 1988 | 6 | 0.180 |
Why?
|
| Mole Rats | 1 | 2019 | 8 | 0.180 |
Why?
|
| Cell Line | 6 | 2015 | 1752 | 0.180 |
Why?
|
| Mandible | 1 | 2000 | 53 | 0.180 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 12 | 0.180 |
Why?
|
| Neovascularization, Physiologic | 2 | 2015 | 164 | 0.180 |
Why?
|
| Species Specificity | 1 | 2020 | 302 | 0.180 |
Why?
|
| Apoptosis | 6 | 2012 | 1640 | 0.180 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 1 | 2019 | 14 | 0.180 |
Why?
|
| Bone Morphogenetic Protein 4 | 4 | 2013 | 17 | 0.180 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 208 | 0.180 |
Why?
|
| Cytoskeletal Proteins | 3 | 1988 | 108 | 0.170 |
Why?
|
| Extremities | 2 | 2013 | 49 | 0.170 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2020 | 231 | 0.170 |
Why?
|
| Nerve Tissue Proteins | 1 | 2000 | 290 | 0.160 |
Why?
|
| Extracellular Matrix Proteins | 3 | 1988 | 144 | 0.160 |
Why?
|
| Neoplasm Proteins | 1 | 2000 | 307 | 0.160 |
Why?
|
| Wnt Proteins | 4 | 2014 | 57 | 0.160 |
Why?
|
| Gene Deletion | 2 | 2012 | 235 | 0.160 |
Why?
|
| Ventricular Remodeling | 1 | 2021 | 318 | 0.160 |
Why?
|
| Retinoid X Receptor alpha | 3 | 2011 | 18 | 0.160 |
Why?
|
| Lac Operon | 3 | 2009 | 54 | 0.150 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2017 | 144 | 0.150 |
Why?
|
| Immunoblotting | 1 | 2017 | 254 | 0.150 |
Why?
|
| Protein Kinases | 1 | 2017 | 122 | 0.150 |
Why?
|
| Embryo, Nonmammalian | 2 | 2015 | 64 | 0.150 |
Why?
|
| Transcription, Genetic | 5 | 2000 | 562 | 0.150 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2021 | 450 | 0.140 |
Why?
|
| Molecular Sequence Data | 6 | 2014 | 1446 | 0.140 |
Why?
|
| Organ Specificity | 2 | 2015 | 167 | 0.140 |
Why?
|
| Cell Cycle | 3 | 2022 | 312 | 0.140 |
Why?
|
| Carrier Proteins | 3 | 2000 | 597 | 0.130 |
Why?
|
| Abnormalities, Multiple | 1 | 1996 | 109 | 0.130 |
Why?
|
| Humans | 12 | 2023 | 68525 | 0.130 |
Why?
|
| Fibrin | 1 | 2015 | 35 | 0.130 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2001 | 43 | 0.130 |
Why?
|
| Chemokines, CXC | 1 | 2015 | 16 | 0.130 |
Why?
|
| Oxidative Stress | 1 | 2019 | 718 | 0.130 |
Why?
|
| Cell Line, Transformed | 1 | 2015 | 100 | 0.130 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 498 | 0.130 |
Why?
|
| Thrombospondins | 1 | 2014 | 5 | 0.130 |
Why?
|
| Cell Hypoxia | 1 | 2015 | 92 | 0.130 |
Why?
|
| Gene Dosage | 2 | 2010 | 47 | 0.130 |
Why?
|
| Wnt Signaling Pathway | 1 | 2014 | 57 | 0.120 |
Why?
|
| Trigeminal Ganglion | 1 | 2013 | 5 | 0.120 |
Why?
|
| Ophthalmic Nerve | 1 | 2013 | 4 | 0.120 |
Why?
|
| Sensory Receptor Cells | 1 | 2013 | 9 | 0.120 |
Why?
|
| Somatomedins | 1 | 2013 | 16 | 0.120 |
Why?
|
| Male | 11 | 2021 | 37281 | 0.120 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 2 | 2005 | 28 | 0.120 |
Why?
|
| Skull | 3 | 2005 | 63 | 0.110 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 2005 | 62 | 0.110 |
Why?
|
| Glucose | 1 | 2015 | 307 | 0.110 |
Why?
|
| Oxygen | 1 | 2015 | 386 | 0.110 |
Why?
|
| Models, Biological | 3 | 2012 | 981 | 0.110 |
Why?
|
| Receptor, TIE-2 | 1 | 2012 | 4 | 0.110 |
Why?
|
| Cell Aggregation | 1 | 2011 | 28 | 0.100 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 61 | 0.100 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2012 | 100 | 0.100 |
Why?
|
| Tamoxifen | 1 | 2011 | 62 | 0.100 |
Why?
|
| Axons | 2 | 2013 | 139 | 0.100 |
Why?
|
| Hepatocytes | 2 | 2005 | 205 | 0.100 |
Why?
|
| Receptor, IGF Type 2 | 1 | 2011 | 13 | 0.100 |
Why?
|
| Dental Enamel | 1 | 2011 | 7 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 282 | 0.100 |
Why?
|
| Genetic Engineering | 1 | 2011 | 41 | 0.100 |
Why?
|
| Antigens, CD | 1 | 2011 | 230 | 0.100 |
Why?
|
| Tissue Distribution | 2 | 2009 | 282 | 0.090 |
Why?
|
| Aldehyde Oxidoreductases | 2 | 2011 | 10 | 0.090 |
Why?
|
| Wnt1 Protein | 2 | 2007 | 9 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 710 | 0.090 |
Why?
|
| Endothelins | 2 | 2008 | 57 | 0.090 |
Why?
|
| Cloning, Molecular | 5 | 1998 | 357 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 434 | 0.090 |
Why?
|
| RNA | 2 | 2009 | 171 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2013 | 617 | 0.090 |
Why?
|
| Growth Substances | 1 | 2009 | 77 | 0.090 |
Why?
|
| Gene Expression | 3 | 2008 | 770 | 0.080 |
Why?
|
| DNA Primers | 1 | 2009 | 302 | 0.080 |
Why?
|
| Endocardial Cushions | 1 | 2008 | 20 | 0.080 |
Why?
|
| Superior Cervical Ganglion | 1 | 2008 | 6 | 0.080 |
Why?
|
| Hepatic Stellate Cells | 1 | 2009 | 53 | 0.080 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2008 | 17 | 0.080 |
Why?
|
| Transgenes | 2 | 2005 | 92 | 0.080 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2008 | 45 | 0.080 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2009 | 160 | 0.080 |
Why?
|
| Carotid Arteries | 1 | 2008 | 110 | 0.080 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2009 | 199 | 0.080 |
Why?
|
| Genes, Homeobox | 2 | 2007 | 15 | 0.080 |
Why?
|
| RNA, Untranslated | 1 | 2007 | 11 | 0.080 |
Why?
|
| Activin Receptors, Type I | 1 | 2006 | 14 | 0.070 |
Why?
|
| Aorta, Thoracic | 2 | 2000 | 211 | 0.070 |
Why?
|
| Connexin 43 | 1 | 2007 | 62 | 0.070 |
Why?
|
| Embryonic Development | 1 | 2007 | 100 | 0.070 |
Why?
|
| Transfection | 3 | 2001 | 782 | 0.070 |
Why?
|
| Crosses, Genetic | 3 | 2005 | 60 | 0.070 |
Why?
|
| Endoderm | 1 | 2005 | 37 | 0.070 |
Why?
|
| Retinoic Acid 4-Hydroxylase | 1 | 2005 | 3 | 0.070 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 1 | 2005 | 9 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2012 | 2550 | 0.070 |
Why?
|
| Retinal Dehydrogenase | 1 | 2005 | 10 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2005 | 16 | 0.070 |
Why?
|
| Neuregulins | 1 | 2005 | 11 | 0.070 |
Why?
|
| NIH 3T3 Cells | 1 | 2005 | 65 | 0.060 |
Why?
|
| Cytokines | 1 | 2009 | 866 | 0.060 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2005 | 71 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2002 | 376 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2005 | 246 | 0.060 |
Why?
|
| Frontal Bone | 1 | 2003 | 4 | 0.060 |
Why?
|
| Biomarkers | 2 | 2007 | 1593 | 0.060 |
Why?
|
| Cell Culture Techniques | 1 | 2005 | 189 | 0.060 |
Why?
|
| Odontogenesis | 1 | 2003 | 1 | 0.060 |
Why?
|
| Gene Targeting | 3 | 2004 | 58 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2005 | 222 | 0.060 |
Why?
|
| Rats | 5 | 2023 | 5300 | 0.060 |
Why?
|
| Acyl-CoA Dehydrogenase | 2 | 2000 | 8 | 0.060 |
Why?
|
| Acyl-CoA Dehydrogenases | 2 | 2000 | 6 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2003 | 51 | 0.060 |
Why?
|
| Proteins | 1 | 2007 | 473 | 0.060 |
Why?
|
| Genes, Reporter | 2 | 2002 | 191 | 0.060 |
Why?
|
| Pulmonary Artery | 1 | 2005 | 323 | 0.060 |
Why?
|
| Bone Morphogenetic Proteins | 3 | 2008 | 43 | 0.060 |
Why?
|
| NFATC Transcription Factors | 2 | 2016 | 40 | 0.060 |
Why?
|
| Uterus | 1 | 2023 | 77 | 0.060 |
Why?
|
| RNA, Messenger | 4 | 2011 | 1663 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 1990 | 1082 | 0.050 |
Why?
|
| Transcription Factor AP-2 | 1 | 2002 | 9 | 0.050 |
Why?
|
| Heart Valves | 2 | 2008 | 171 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2005 | 1199 | 0.050 |
Why?
|
| Cell Division | 2 | 2003 | 541 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2003 | 230 | 0.050 |
Why?
|
| Erythroid Precursor Cells | 1 | 2001 | 7 | 0.050 |
Why?
|
| Ligands | 1 | 2022 | 317 | 0.050 |
Why?
|
| Aorta | 2 | 2006 | 316 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2001 | 24 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2002 | 411 | 0.050 |
Why?
|
| Epistasis, Genetic | 1 | 2001 | 32 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2001 | 165 | 0.050 |
Why?
|
| Dimerization | 1 | 2001 | 99 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2001 | 63 | 0.050 |
Why?
|
| Epithelium | 1 | 2001 | 172 | 0.050 |
Why?
|
| Myelin P2 Protein | 1 | 2000 | 3 | 0.050 |
Why?
|
| Peroxisome Proliferators | 1 | 2000 | 5 | 0.050 |
Why?
|
| Cytochrome P-450 CYP4A | 1 | 2000 | 6 | 0.050 |
Why?
|
| Fatty Acid-Binding Protein 7 | 1 | 2000 | 6 | 0.050 |
Why?
|
| Acyl-CoA Oxidase | 1 | 2000 | 12 | 0.050 |
Why?
|
| Apolipoprotein C-III | 1 | 2000 | 12 | 0.050 |
Why?
|
| Apolipoproteins C | 1 | 2000 | 15 | 0.050 |
Why?
|
| Mixed Function Oxygenases | 1 | 2000 | 35 | 0.050 |
Why?
|
| Apolipoprotein A-I | 1 | 2000 | 29 | 0.050 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2000 | 30 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2014 | 95 | 0.050 |
Why?
|
| Protein Multimerization | 1 | 2001 | 71 | 0.050 |
Why?
|
| Prostate | 1 | 2001 | 116 | 0.050 |
Why?
|
| Oxidoreductases | 1 | 2000 | 117 | 0.050 |
Why?
|
| Triglycerides | 1 | 2000 | 184 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2001 | 489 | 0.050 |
Why?
|
| Homozygote | 3 | 1995 | 119 | 0.050 |
Why?
|
| Teratogens | 1 | 1999 | 11 | 0.050 |
Why?
|
| Genomic Library | 2 | 1996 | 18 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2000 | 178 | 0.040 |
Why?
|
| Cleft Palate | 1 | 1999 | 34 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2020 | 135 | 0.040 |
Why?
|
| Cholesterol | 1 | 2000 | 331 | 0.040 |
Why?
|
| Long-Term Potentiation | 1 | 1998 | 53 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2009 | 58 | 0.040 |
Why?
|
| Maze Learning | 1 | 1998 | 138 | 0.040 |
Why?
|
| Chimera | 1 | 1998 | 33 | 0.040 |
Why?
|
| Retinoids | 2 | 1998 | 122 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2008 | 57 | 0.040 |
Why?
|
| Veins | 1 | 1997 | 68 | 0.040 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 1998 | 106 | 0.040 |
Why?
|
| Coronary Vessel Anomalies | 1 | 1997 | 45 | 0.040 |
Why?
|
| Bone and Bones | 2 | 2013 | 145 | 0.040 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 2016 | 11 | 0.040 |
Why?
|
| Exons | 1 | 1996 | 122 | 0.040 |
Why?
|
| Synapses | 1 | 1998 | 222 | 0.040 |
Why?
|
| Myosin Light Chains | 1 | 1996 | 18 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 1996 | 181 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 1998 | 222 | 0.030 |
Why?
|
| Gene Library | 2 | 1998 | 68 | 0.030 |
Why?
|
| Neuronal Plasticity | 1 | 1998 | 274 | 0.030 |
Why?
|
| Nervous System Malformations | 1 | 1995 | 7 | 0.030 |
Why?
|
| Hippocampus | 1 | 1998 | 471 | 0.030 |
Why?
|
| Hormones | 1 | 1995 | 42 | 0.030 |
Why?
|
| Nervous System | 1 | 1995 | 45 | 0.030 |
Why?
|
| Homeobox Protein Nkx-2.5 | 1 | 2014 | 27 | 0.030 |
Why?
|
| Muscles | 3 | 1996 | 158 | 0.030 |
Why?
|
| Angiography | 1 | 2015 | 194 | 0.030 |
Why?
|
| Restriction Mapping | 2 | 1993 | 85 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 1994 | 43 | 0.030 |
Why?
|
| Cardiomegaly | 1 | 1995 | 213 | 0.030 |
Why?
|
| beta Catenin | 1 | 2014 | 73 | 0.030 |
Why?
|
| Rhombencephalon | 2 | 2005 | 7 | 0.030 |
Why?
|
| RNA Probes | 2 | 1995 | 15 | 0.030 |
Why?
|
| Bone Development | 1 | 2013 | 37 | 0.030 |
Why?
|
| Peptides | 1 | 1996 | 455 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 1995 | 765 | 0.030 |
Why?
|
| Amelogenin | 1 | 2011 | 1 | 0.020 |
Why?
|
| Physical Chromosome Mapping | 1 | 2011 | 8 | 0.020 |
Why?
|
| Keratolytic Agents | 1 | 2011 | 4 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1993 | 268 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2011 | 35 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 52 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 682 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2011 | 122 | 0.020 |
Why?
|
| Smad4 Protein | 1 | 2009 | 10 | 0.020 |
Why?
|
| Materials Testing | 1 | 2011 | 263 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2009 | 33 | 0.020 |
Why?
|
| Activated-Leukocyte Cell Adhesion Molecule | 1 | 2009 | 1 | 0.020 |
Why?
|
| Desmin | 1 | 2009 | 13 | 0.020 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2009 | 20 | 0.020 |
Why?
|
| Neurons | 1 | 1995 | 881 | 0.020 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1988 | 26 | 0.020 |
Why?
|
| Mosaicism | 1 | 1988 | 21 | 0.020 |
Why?
|
| Genetic Markers | 2 | 2002 | 144 | 0.020 |
Why?
|
| Receptor, Notch1 | 1 | 2008 | 11 | 0.020 |
Why?
|
| Endothelin-3 | 1 | 2008 | 2 | 0.020 |
Why?
|
| Hyaluronan Receptors | 1 | 2009 | 142 | 0.020 |
Why?
|
| Neurites | 1 | 2008 | 18 | 0.020 |
Why?
|
| Receptors, Endothelin | 1 | 2008 | 30 | 0.020 |
Why?
|
| Mitogens | 1 | 2008 | 45 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2008 | 78 | 0.020 |
Why?
|
| Salivary Glands | 1 | 2008 | 52 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2009 | 397 | 0.020 |
Why?
|
| Mice, Inbred DBA | 2 | 2001 | 120 | 0.020 |
Why?
|
| Deoxyribonuclease BamHI | 1 | 1987 | 2 | 0.020 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1987 | 6 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 1987 | 49 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2007 | 38 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2009 | 370 | 0.020 |
Why?
|
| Receptor, EphA4 | 1 | 2005 | 1 | 0.020 |
Why?
|
| Early Growth Response Protein 2 | 1 | 2005 | 2 | 0.020 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2005 | 15 | 0.020 |
Why?
|
| Neural Tube Defects | 1 | 2005 | 27 | 0.020 |
Why?
|
| Myosins | 1 | 1985 | 34 | 0.020 |
Why?
|
| Angiopoietin-1 | 1 | 2004 | 12 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2004 | 54 | 0.020 |
Why?
|
| Drosophila | 1 | 1985 | 37 | 0.020 |
Why?
|
| Cell Survival | 1 | 2007 | 901 | 0.020 |
Why?
|
| Twist-Related Protein 1 | 1 | 2003 | 13 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p19 | 1 | 2003 | 5 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2003 | 16 | 0.010 |
Why?
|
| Cues | 1 | 2008 | 654 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2004 | 219 | 0.010 |
Why?
|
| Actins | 1 | 1985 | 249 | 0.010 |
Why?
|
| Parietal Bone | 1 | 2002 | 2 | 0.010 |
Why?
|
| Paired Box Transcription Factors | 1 | 2002 | 8 | 0.010 |
Why?
|
| PAX3 Transcription Factor | 1 | 2002 | 5 | 0.010 |
Why?
|
| Cranial Sutures | 1 | 2002 | 7 | 0.010 |
Why?
|
| Meninges | 1 | 2002 | 7 | 0.010 |
Why?
|
| Galactosides | 1 | 2001 | 5 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2002 | 137 | 0.010 |
Why?
|
| Biological Evolution | 1 | 2002 | 86 | 0.010 |
Why?
|
| Testis | 1 | 2001 | 37 | 0.010 |
Why?
|
| Ovary | 1 | 2001 | 99 | 0.010 |
Why?
|
| Osteogenesis | 1 | 2002 | 152 | 0.010 |
Why?
|
| Indoles | 1 | 2001 | 146 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2001 | 492 | 0.010 |
Why?
|
| Protein Binding | 1 | 2002 | 1027 | 0.010 |
Why?
|
| Space Perception | 1 | 1998 | 44 | 0.010 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 1998 | 87 | 0.010 |
Why?
|
| Rats, Mutant Strains | 1 | 1998 | 14 | 0.010 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 1998 | 19 | 0.010 |
Why?
|
| Electron Transport Complex I | 1 | 1998 | 20 | 0.010 |
Why?
|
| Mitochondria, Heart | 1 | 1998 | 53 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1998 | 251 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 1998 | 236 | 0.010 |
Why?
|
| Peptide Biosynthesis | 1 | 1996 | 5 | 0.010 |
Why?
|
| Endocardial Cushion Defects | 1 | 1996 | 11 | 0.010 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 1996 | 17 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1998 | 314 | 0.010 |
Why?
|
| Genitalia | 1 | 1996 | 4 | 0.010 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 1996 | 59 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 1996 | 16 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1996 | 236 | 0.010 |
Why?
|
| Urinary Tract | 1 | 1996 | 10 | 0.010 |
Why?
|
| Trachea | 1 | 1996 | 48 | 0.010 |
Why?
|
| Microscopy, Video | 1 | 1995 | 27 | 0.010 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 1995 | 40 | 0.010 |
Why?
|
| Phenylephrine | 1 | 1995 | 61 | 0.010 |
Why?
|
| Cell Size | 1 | 1995 | 76 | 0.010 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1995 | 54 | 0.010 |
Why?
|
| Ventricular Function | 1 | 1995 | 93 | 0.010 |
Why?
|
| Heart Conduction System | 1 | 1995 | 119 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2001 | 778 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 1995 | 226 | 0.010 |
Why?
|
| Heart Atria | 1 | 1995 | 206 | 0.010 |
Why?
|
| Esophagus | 1 | 1996 | 303 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 1995 | 383 | 0.010 |
Why?
|
| DNA Probes | 1 | 1993 | 57 | 0.010 |
Why?
|
| Skin Physiological Phenomena | 1 | 1993 | 13 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 1993 | 71 | 0.010 |
Why?
|
| Thymus Gland | 1 | 1993 | 97 | 0.010 |
Why?
|
| Heterozygote | 1 | 1993 | 174 | 0.010 |
Why?
|
| Time Factors | 1 | 2001 | 4655 | 0.010 |
Why?
|
| Bone Marrow | 1 | 1993 | 168 | 0.010 |
Why?
|
| Spleen | 1 | 1993 | 301 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1993 | 228 | 0.010 |
Why?
|
| Brain | 1 | 2002 | 2175 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1987 | 95 | 0.000 |
Why?
|
| Protein Biosynthesis | 1 | 1987 | 181 | 0.000 |
Why?
|
| DNA | 1 | 1987 | 597 | 0.000 |
Why?
|